CTEPH Clinical Trial
Official title:
An Investigator-initiated, Multicenter, Phase 3, Randomized, Single-blind, Double-dummy, Parallel-group Study of Evaluate the Efficacy and Safety of Edoxaban Versus Warfarin (Vitamin K Antagonist) in Subjects With Chronic Thromboembolic Pulmonary Hypertension Taking Warfarin (Vitamin K Antagonist) at Baseline: KABUKI
This is phase III trial to evaluate whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05140525 -
Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH
|
Phase 3 | |
Recruiting |
NCT06105242 -
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
|
||
Completed |
NCT03083093 -
CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
|
||
Completed |
NCT03245268 -
International BPA Registry
|
||
Recruiting |
NCT02660463 -
Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany
|
N/A | |
Completed |
NCT01393327 -
Feasibility and Influence of Exercise Therapy on Oxygen Uptake and Right Heart Function in CTEPH Patients After PEA
|
N/A | |
Recruiting |
NCT01672203 -
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism
|
N/A | |
Completed |
NCT03953560 -
Symptom-related Screening for Early Detection of CTEPH.
|
N/A | |
Completed |
NCT02656238 -
New International CTEPH Database
|
||
Recruiting |
NCT05480137 -
OCT Evaluates the Effects of CTEPH Treated by Scoring Balloon
|
N/A | |
Terminated |
NCT03273257 -
Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)
|
Phase 2 | |
Recruiting |
NCT05629052 -
TrEatment Approach in the Multimodal Era Registry
|
||
Completed |
NCT04207593 -
The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia
|
Phase 2 |